CASP3 and breast cancer: Pterostilbene treatment inhibited MCF-7 and MDA-MB-231 breast cancer growth in vitro through caspase-3, -7-dependent apoptosis; indeed, it decreased MMP and increased superoxide anions, activating downstream effector caspases [153].